perflutren has been researched along with Peripheral Vascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, S; Das, T; Nayak, S; Padhi, TR | 1 |
| Chan, WM; Lai, TY; Lam, DS; Li, H; Liu, DT; Tong, JP | 1 |
2 other study(ies) available for perflutren and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Pneumatic displacement and intra-vitreal bevacizumab in management of sub-retinal and sub-retinal pigment epithelial hemorrhage at macula in polypoidal choroidal vasculopathy (PCV): rationale and outcome.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid Diseases; Combined Modality Therapy; Female; Fluorocarbons; Humans; Intravitreal Injections; Male; Middle Aged; Peripheral Vascular Diseases; Pressure; Retinal Hemorrhage; Retinal Pigment Epithelium; Treatment Outcome | 2015 |
Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
Topics: Choroid; Choroid Diseases; Combined Modality Therapy; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Indocyanine Green; Injections; Male; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retinal Hemorrhage; Treatment Outcome; Verteporfin; Visual Acuity | 2005 |